Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD) [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of ADX-914 for moderate-to-severe atopic dermatitis, sponsored by Q32 Bio I…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis. [Phase 2]
Phase 2 trial PF-07038124 in patients with Atopic dermatitis and Plaque psoriasis has completed, with results posted on 2024-10-02.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating subcutaneous lirentelimab (AK002) for atopic dermatitis was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India [Phase 3]
A Phase 3 study evaluating abrocitinib tablets for atopic dermatitis in India has completed, and the trial results have been posted.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
This clinical trial update describes a study to identify cutaneous and blood biomarkers that predict response to systemic treatments across …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating Upadacitinib for Atopic Dermatitis–associated sleep disturbance has been withdrawn.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Meditation in Inflammatory Dermatosis [NA]
A clinical trial update indicates a sponsor in Paris is recruiting a study to evaluate meditation for inflammatory skin conditions, includin…
-
FDA approval · 2024-09-12FDA Approved: DUPIXENT — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Dupixent (dupilumab) submitted by sanofi-aventis U.S. LLC.
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Treatment of Nighttime Pruritus in Atopic Dermatitis [EARLY_Phase 1]
An early-phase clinical trial assessing treatment for nighttime pruritus in atopic dermatitis was withdrawn.
-
FDA approval · 2024-08-22FDA Approved: BETAMETHASONE VALERATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original ANDA for Betamethasone Valerate topical (Alembic Pharmaceuticals), a generic corticosteroid product for inflammator…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms [NA]
Completed clinical trial evaluating the efficacy of marine by-product hydrolysate in reducing Atopic Dermatitis symptoms.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Efficacy of Dipotassium Glycyrrhizinate Emollients in the Maintenance Treatment of Adult Atopic Dermatitis [NA]
Clinical trial update on the maintenance use of dipotassium glycyrrhizinate emollients for adults with atopic dermatitis; study status is co…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
This ClinicalTrials.gov entry describes a recruiting study investigating how intrinsic and extrinsic factors influence atopic dermatitis und…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement [Phase 2]
Phase 2 study evaluating ruxolitinib cream for facial/neck involvement in atopic dermatitis; the trial has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD) [Phase 3]
A Phase 3 study evaluating the efficacy of difamilast ointment in patients with mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
A China-based clinical research project sponsored by Peking University First Hospital is currently recruiting participants for standardized …
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial results evaluating the efficacy and safety of nemolizumab in adults with moderate-to-severe atopic dermatitis have been posted…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial update reporting efficacy and safety data for nemolizumab in adults with moderate-to-severe atopic dermatitis; results have be…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis. [Phase 1]
Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of LNK01004 ointment in adults with atopic dermatitis; the study has…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic Dermatitis [NA]
A completed clinical trial comparing Emollient Plus to Urea 10% for mild-to-moderate atopic dermatitis.
-
FDA approval · 2024-08-14FDA Approved: MOMETASONE FUROATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for mometasone furoate from Glenmark Pharmaceuticals Inc., USA under an ANDA.
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive [Phase 1]
This Phase 1 study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single intravenous dose of GSK1070806 in …
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO)
A completed clinical trial analyzing filmed sequences to assess cutaneous discomfort in infants under one year with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis [Phase 3]
Open-label Phase 3 study assessing the long-term safety of difamilast 1% ointment in mild-to-moderate atopic dermatitis; the trial has compl…
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis [Phase 1]
A Phase 1 study evaluating BxC-I17e for moderate to severe atopic dermatitis has been withdrawn.